Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-03

Clinical Trial Update: Simvastatin in Uveitis [Phase 2]

View source ↗

Summary

Phase 2 trial updating the use of simvastatin for uveitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology | Conditions: Uveitis | Phase 2 | Status: COMPLETED